Eli Lilly secures obesity drug coverage across top three U.S. PBMs
Eli Lilly (NYSE:LLY) announced a major commercial milestone for its metabolic health franchise, securing comprehensive formulary placement from the three largest pharmacy benefit managers (PBMs) in the United States to cover its entire obesity medicine portfolio.










